Found 126 matching trials
A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
PHASE2We define refractory nasopharyngeal carcinoma as the following: recurrence ...
Location
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center
Plasma Endostatin Predicts Outcome of Septic AKI
N/AIntroduction: Acute kidney injury (AKI) occurs up to 50% of patients admitt...
Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization
N/AThis project will include at least 40 patients with hepatocellular carcinom...
Location
Kaohsiung Medical University Hospital
Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer
PHASE3The primary objectives of this control, single-center clinical study of End...
Location
Cancer Hospital of Xinjiang Medical University
Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma
PHASE4Explore the efficacy and safety of the treatment of Endostar continuous int...
Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.
PHASE2To study safety and efficacy of intravenous pump of recombinant human endos...
Location
Sichuan Provincial People Hospital
Nab-PCE vs PC for MM After Failure of Anti-PD-1
PHASE2This is a randomized controlled clinical trial of nab-paclitaxel + carbopla...
Location
Beijing Cancer Hospital
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.
PHASE2Here we are going to find a method by using available multiple drugs includ...
Location
Peking University Third Hospital
Vascular Endothelial Growth Factor and Endostatin in Angiogenesis After Acute Ischemic Stroke
N/AVascular endothelial growth factor (VEGF) and Endostatin (ES) participate a...
Location
Shanghai Sixth People's Hospital
Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
PHASE1Resistance of hypoxic tumor cells to radiation is a significant reason of f...
Location
Zhejiang Cancer Hospital